Viridos
United States · $25.0M raised
- Business Model
- B2B
- Website
- viridos.com
- Total Funding
- $25.0M
- Last Round
- $25.0M Series AMar 2023
- Rounds
- 1
About
Viridos is a biotechnology company harnessing synthetic biology and microalgae photosynthesis to create sustainable alternatives to fossil fuels.
Summary
Viridos is a Biotech company based in United States. It has raised $25.0M in total across 1 round, most recently a $25.0M Series A round in Mar 2023. Investors include Breakthrough Energy Ventures, United Airlines Ventures and Draper Associates.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2023
Investors
Similar Companies
Decarbonizing the chemicals industry.
Green steel company using hydrogen and renewable electricity to decarbonize steel production. For...
Leading North American energy infrastructure platform.
Self-driving cars.
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...